APA (7th ed.) Citation

X, M., ZL, T., VS, M., DM, B., JF, K., JL, K., . . . DJ, M. (2024). CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression. Clinical pharmacology and therapeutics, 115(5), 1065. https://doi.org/10.1002/cpt.3162

Chicago Style (17th ed.) Citation

X, Men, et al. "CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression." Clinical Pharmacology and Therapeutics 115, no. 5 (2024): 1065. https://doi.org/10.1002/cpt.3162.

MLA (9th ed.) Citation

X, Men, et al. "CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression." Clinical Pharmacology and Therapeutics, vol. 115, no. 5, 2024, p. 1065, https://doi.org/10.1002/cpt.3162.